Lumos Pharma Is A Clinical Stage Biopharmaceutical Company Based In Austintexasfounded In 2011The Company Is Focused On Developing Innovative Treatments For Rare Diseasesaiming To Address Significant Unmet Medical Needs In Healthcarelumos Pharma S Main Product Candidate Is Lum 201An Orally Administered Small Molecule Growth Hormone Secretagogue Currently In Phase Iii Clinical Trialsthis Treatment Targets Idiopathic Pediatric Growth Hormone Deficiency And Other Rare Endocrine Disordersthe Company Is Also Investigating Lum 201 For Potential Applications In Nonalcoholic Fatty Liver Diseaseidiopathic Short Statureand Prader Willi Syndromelumos Pharma Collaborates With Massachusetts General Hospital To Further Research On Lum 201 For Nonalcoholic Fatty Liver Disease Led By Ceo Richard Hawkinslumos Pharma Operates With A Dedicated Team And Is Listed On The Nasdaq Under The Ticker Symbol Lumo
No conferences found for this company.
| Company Name | Lumos Pharma Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
